Literature DB >> 9027653

Ulcerative colitis with overexpression of p53 preceding overt histological abnormalities of the epithelium.

K Matsuda1, H Watanabe, Y Ajioka, M Kobayashi, H Saito, M Sasaki, K Yasuda, A Kuwabara, K Nishikura, T Muto.   

Abstract

A 53-year-old man with a 22-year history of ulcerative colitis(UC) (pancolitis), had an ulcerating rectal tumor. Resection of the rectum and sigmoid colon was performed. Pathology showed an expansive ulcerating adenocarcinoma tumor (type 2) invading the adventitia against a background of UC in a resolving phase. Dysplasia was also found in granular and flat mucosa adjacent to the invading carcinoma. Immunostaining for p53 showed diffuse positivity in both the carcinoma and dysplasia, and also in the mucosa with indefinite dysplasia or no dysplasia neighboring the dysplasia and carcinoma. Mapping of neoplasms and the area with p53 protein overexpression showed that the grade of dysplasia increased as the lesion approached the invasive carcinoma and that the mucosa with dysplasia was surrounded by mucosa without dysplasia or indefinite for dysplasia, but with p53 protein overexpression. In some areas without dysplasia showing p53 overexpression, there was significant morphometric enlargement of the area and diameter of the nucleus p53 Immunostaining is a good marker for assessing the genetic alterations that precede histological abnormalities and for diagnosing carcinoma in UC. Objective findings such as p53-protein overexpression and morphometric values should be used to evaluate cytological abnormalities in UC, as well as in common colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9027653     DOI: 10.1007/bf02358616

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  31 in total

1.  Consistency in the terminology of colorectal dysplasia.

Authors:  R R Pascal
Journal:  Hum Pathol       Date:  1988-11       Impact factor: 3.466

2.  Precancer and carcinoma in chronic ulcerative colitis. A histopathological and clinical investigation.

Authors:  L Hultén; J Kewenter; C Ahrén
Journal:  Scand J Gastroenterol       Date:  1972       Impact factor: 2.423

3.  "Precancer" lesions in ulcerative colits. A retrospective study of rectal biopsy and colectomy specimens.

Authors:  J H Yardley; D F Keren
Journal:  Cancer       Date:  1974-09       Impact factor: 6.860

4.  General rules for clinical and pathological studies on cancer of the colon, rectum and anus. Part I. Clinical classification. Japanese Research Society for Cancer of the Colon and Rectum.

Authors: 
Journal:  Jpn J Surg       Date:  1983-11

5.  Carcinoma and epithelial dysplasia complicating ulcerative colitis.

Authors:  M G Cook; J C Goligher
Journal:  Gastroenterology       Date:  1975-05       Impact factor: 22.682

6.  p53 immunostaining distinguishes malignant from benign lesions of the gall-bladder.

Authors:  Y Oohashi; H Watanabe; Y Ajioka; K Hatakeyama
Journal:  Pathol Int       Date:  1995-01       Impact factor: 2.534

7.  Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy.

Authors:  M O Blackstone; R H Riddell; B H Rogers; B Levin
Journal:  Gastroenterology       Date:  1981-02       Impact factor: 22.682

8.  Correlation of p53 protein expression with apoptotic incidence in colorectal neoplasia.

Authors:  M Kobayashi; H Watanabe; Y Ajioka; M Yoshida; J Hitomi; H Asakura
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

9.  Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis.

Authors:  W R Connell; J E Lennard-Jones; C B Williams; I C Talbot; A B Price; K H Wilkinson
Journal:  Gastroenterology       Date:  1994-10       Impact factor: 22.682

10.  Increased expression of mutant forms of p53 oncogene in primary lung cancer.

Authors:  R Iggo; K Gatter; J Bartek; D Lane; A L Harris
Journal:  Lancet       Date:  1990-03-24       Impact factor: 79.321

View more
  1 in total

1.  Mutations of p53 in morphologically non-neoplastic mucosa of long-standing ulcerative colitis.

Authors:  H Takaku; Y Ajioka; H Watanabe; H Hashidate; S Yamada; J Yokoyama; S Kazama; T Suda; K Hatakeyama
Journal:  Jpn J Cancer Res       Date:  2001-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.